Literature DB >> 11773936

The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.

K B Zarnke1, M Levine, F A McAlister, N R Campbell, M G Myers, D W McKay, P Bolli, G Honos, M Lebel, K Mann, T W Wilson, C Abbott, S Tobe, E Burgess, S Rabkin.   

Abstract

OBJECTIVE: To provide updated, evidence-based recommendations for the diagnosis and assessment of high blood pressure in adults. OPTIONS: For people with high blood pressure, the assignment of a diagnosis of hypertension depends on the appropriate measurement of blood pressure, the level of the blood pressure elevation, the duration of follow-up and the presence of concomitant vascular risk factors, target organ damage and established atherosclerotic diseases. For people diagnosed with hypertension, defining the overall risk of adverse cardiovascular outcomes requires laboratory testing, a search for target organ damage and an assessment of the modifiable causes of hypertension. Out-of-clinic blood pressure assessment and echocardiography are options for selected patients. OUTCOMES: People at increased risk of adverse cardiovascular outcomes and were identified and quantified. EVIDENCE: Medline searches were conducted from the period of the last revision of the Canadian recommendations for the management of hypertension (May 1998 to October 2000). Reference lists were scanned, experts were polled, and the personal files of the subgroup members and authors were used to identify other studies. All relevant articles were reviewed and appraised, using prespecified levels of evidence, by content experts and methodological experts. VALUES: A high value was placed on the identification of people at increased risk of cardiovascular morbidity and mortality. BENEFITS, HARMS AND COSTS: The identification of people at higher risk of cardiovascular disease will permit counselling for lifestyle manoeuvres and the introduction of antihypertensive drugs to reduce blood pressure for patients with sustained hypertension. In certain settings, and for specific classes of drugs, blood pressure lowering has been associated with reduced cardiovascular morbidity and/or mortality. RECOMMENDATIONS: The present document contains detailed recommendations pertaining to aspects of the diagnosis and assessment of patients with hypertension, including the accurate measurement of blood pressure, criteria for the diagnosis of hypertension and recommendations for follow-up, routine and optional laboratory testing, assessment for renovascular hypertension, home and ambulatory blood pressure monitoring, and the role of echocardiography in hypertension. VALIDATION: All recommendations were graded according to strength of the evidence and voted on by the Canadian Hypertension Recommendations Working Group. Only the recommendations achieving high levels of consensus are reported here. These guidelines will be updated annually. ENDORSEMENT: These recommendations are endorsed by the Canadian Hypertension Society, The Canadian Coalition for High Blood Pressure Prevention and Control, The College of Family Physicians of Canada, The Heart and Stroke Foundation of Canada, The Adult Disease Division and Bureau of Cardio-Respiratory Diseases and Diabetes at the Centre for Chronic Disease Prevention and Control of Health Canada.

Entities:  

Mesh:

Year:  2001        PMID: 11773936

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  2001 Canadian hypertension recommendations. What has changed?

Authors: 
Journal:  Can Fam Physician       Date:  2002-10       Impact factor: 3.275

2.  The 2001 Canadian hypertension recommendations: take-home messages.

Authors:  Norman R C Campbell; Denis Drouin; Ross D Feldman
Journal:  CMAJ       Date:  2002-09-17       Impact factor: 8.262

3.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Authors:  B R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

4.  Circadian and circaseptan (about-weekly) aspects of immigrant Indians' blood pressure and heart rate in California, USA.

Authors:  B Sundaram; D C Holley; G Cornélissen; D Naik; R Hanumansetty; R B Singh; K Otsuka; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

Review 5.  Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective.

Authors:  Paul K Whelton
Journal:  Can J Cardiol       Date:  2019-02-27       Impact factor: 5.223

6.  The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

Authors:  Raj S Padwal; Brenda R Hemmelgarn; Finlay A McAlister; Donald W McKay; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael Hill; Jeff Mahon; Martin G Myers; Carl Abbott; Ernest L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Nadia A Khan; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.